Skip to main content
Caplight Logo









UroSense

UroSense

Private
LondonHealthcare & Life Scienceshttps://urosense.com

Last Round

Grant

Mar 26, 2021

Total Funding Raised

$13,750

Company Overview

UroSense is a healthtech company that develops sensor-enabled medical devices for monitoring urine output and core body temperature to assist in the prevention and management of catheter-associated infections.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

Foley cathetercatheter-associated urinary tract infectionsCAUTImedical deviceinfection preventionurology devicepatient safetymedtechsmart catheterIoT medical deviceclinical innovationhospital equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

UroSense Comparables

Compare UroSense with similar companies based on industry and business-model similarity.

UroSense comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
The Flume Catheter Company
91%
Camstent
87%
Poiesis Medical
87%

UroSense Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 26, 2021

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 26, 2021

    $14K grant received from WE Innovate.

UroSense Filings

Explore SEC and related filing metadata, where available.

UroSense filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about UroSense's valuation, stock price, and market status.

Is UroSense a public or private company?

UroSense is a private company.

What is the current stock price of UroSense?

UroSense is a private company with no public stock price. No recent secondary market data is available.

How much is UroSense worth (valuation)?

Valuation information for UroSense is not publicly available.

Can I buy UroSense stock?

UroSense shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was UroSense's last funding round?

UroSense's most recent funding round was Grant on March 26, 2021.

Who are the main investors in UroSense?

Investor information for UroSense is not publicly disclosed.

Will UroSense IPO soon?

No public IPO plans have been announced for UroSense.

How can I track UroSense secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor UroSense's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Year Founded2020
Last FundingMar 26, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?